Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study

Fleischman, R., Durez, P., Genovese, M., Keystone, E. M., Pavelka, L., Pavlik-Gaylord, S., Kirsch, T. M., & Sridharan, S. (2006). Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study. Annals of the Rheumatic Diseases, 65, 339. https://hdl.handle.net/2078.5/139754 (Original work published 2006)